Numerous pharmaceuticals are formulated as ionized salts, incorporating elements like sodium or potassium, to enhance their pharmacokinetic profiles
As with any procedure that involves inserting a needle into a vein, IV infusions carry some risks, including discomfort, bruising or swelling at the site and, less commonly, infection or reaction
Research involving KPV has focused on several processes relevant to ulcerative colitis: Excessive cytokine production Intestinal epithelial damage Macrophage activation NF-kappa B signaling Mucosal healing Colon-targeted peptide delivery Intestinal-barrier disruption Animal research found significant anti-inflammatory effects in two models of colitis and proposed KPV as an interesting candidate for inflammatory bowel disease research
Elsevier, Amsterdam, The Netherlands, pp 639667 Baker AF, Adab KN, Raghunand N, Chow H, Stratton SP, Squire SW, Boice M, Pestano LA, Kirkpatrick DL, Dragovich T (2013) A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers
Almost all of the published research involves animal studies